48H SALE 20% OFF SITEWIDE
30% OFF ORDERS OVER $500

Mazdutide peptide therapy benefits include:

Weight management

• Significant weight loss: In a phase 3 trial (GLORY-1), once-weekly mazdutide led to an average body weight reduction of up to 14.8%.
• Reduced appetite: Mazdutide suppresses appetite and slows down digestion, allowing people to feel satisfied with less food and reduce their overall calorie intake.
• Increased energy expenditure: By activating the glucagon receptor, mazdutide increases the body's energy consumption, which contributes to greater weight loss. 

Improved metabolic health

• Enhanced glycemic control: In patients with type 2 diabetes, mazdutide has been shown to significantly reduce blood glucose levels (HbA1c) and improve insulin sensitivity.
• Reduced liver fat: Studies have demonstrated that mazdutide dramatically reduces liver fat content, with some participants in a phase 3 trial achieving up to an 80% reduction.
• Lowered cardiometabolic risk factors: Mazdutide treatment is associated with improvements in various cardiovascular risk factors, including:
• Reduced blood pressure (both systolic and diastolic)
• Decreased total cholesterol and LDL ("bad") cholesterol
• Lowered triglycerides
• Reduced serum uric acid 

Potential cognitive benefits

• Improved cognitive function: A preclinical study found that mazdutide improved cognitive function in mice with diabetes-associated cognitive dysfunction. The effect was shown to be greater than with GLP-1 agonists alone, suggesting a neuroprotective benefit. 

This product is for research only, not human consumption.